表紙
市場調査レポート

オーソバイオロジクスの世界市場:2016〜2020年

Global Orthobiologics Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 353173
出版日 ページ情報 英文 76 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
オーソバイオロジクスの世界市場:2016〜2020年 Global Orthobiologics Market 2016-2020
出版日: 2016年02月17日 ページ情報: 英文 76 Pages
概要

オーソバイオロジクスはバイオマテリアルと細胞に基づく治療を用いて骨の修復や骨の退化を防止し、安定性を図る最新の医療分野です。オーソバイオロジクスの技術革新によって、骨の治癒プロセスを加速させる骨グラフトや組織再生製品の開発につながっています。世界のオーソバイオロジクス市場は、2016〜2020年にかけCAGR7.03%で拡大すると予測されています。

当レポートでは、世界のオーソバイオロジクス市場の現状と今後の成長見通し、地域別動向とともに、市場の動向と課題、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 オーソバイオロジクス開発資金

  • 治験中のオーソバイオロジクス製品

第6章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 製品別セグメンテーション

第8章 処置別市場セグメンテーション

  • 脊椎固定手術
  • 整形外科外傷および再建手術

第9章 地域別セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第10章 市場促進因子

第11章 促進因子の影響

第12章 市場の課題

第13章 促進因子および課題の影響

第14章 市場動向

第15章 ベンダー環境

  • 競合シナリオ
  • DePuy Synthes
  • Medtronic
  • Sanofi
  • Stryker
  • Zimmer Biomet
  • その他の注目すべきベンダー

第16章 付録

第17章 Technavioについて

図表

目次
Product Code: IRTNTR8261

About Orthobiologics

Orthobiologics is an advancing medical field that involves the use of biomaterials and cell-based therapies to repair broken bones, prevent bone degeneration, and provide bone stability. Orthobiologic products are obtained from naturally occurring materials. These products help treat people with long-term disabling musculoskeletal disorders and injuries. Innovations in orthobiologics led to the development of bone grafts and tissue regeneration products that accelerate the bone healing process, reducing hospital visits, and stays.

Technavio's analysts forecast the global orthobiologics market to grow at a CAGR of 7.03% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global orthobiologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of:

  • Stem cells
  • Bone morphogenetic proteins
  • Synthetic bone grafts
  • Viscosupplements
  • Demineralized bone matrix
  • Allografts

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Orthobiologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • DePuy Synthes
  • Medtronic
  • Sanofi
  • Stryker
  • Zimmer Biomet

Other Prominent Vendors

  • Alphatec Spine
  • AlloSource
  • AMEDICA
  • Anika Therapeutics
  • Arthrex
  • Baxter
  • BBS-Bioactive Bone Substitutes
  • Berkeley Advanced Biomaterial
  • Biomimetic Therapeutics
  • Bioventus
  • Bone Therapeutics
  • Ceramisys
  • Geistlich Bio-Oss
  • Graftys
  • Integra Life Sciences
  • ISTO Technologies
  • Keramat
  • K2M
  • NovaBone
  • Orthogem
  • Orthofix International
  • OsteoMed
  • RTI Surgical
  • Sigma Graft
  • Smith & Nephew
  • Straumann
  • Wright Medical
  • Xtant Medical

Market driver

  • Rise in strategic partnerships for marketing
  • For a full, detailed list, view our report

Market challenge

  • High cost of spine fusion surgery
  • For a full, detailed list, view our report

Market trend

  • Funds to enhance orthobiologics
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Funding for orthobiologics development

  • Orthobiologic products under clinical trial

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by product

  • Global orthobiologics market by stem cells
  • Global orthobiologics market by bone morphogenetic proteins
  • Global orthobiologics market by synthetic bone grafts
  • Global orthobiologics market by viscosupplements
  • Global orthobiologics market by demineralized bone matrix
  • Global orthobiologics market by allografts

PART 08: Market segmentation by procedure

  • Spinal fusion surgery
  • Orthopedic trauma and reconstruction surgery

PART 09: Geographical segmentation

  • Orthobiologics market in Americas
  • Orthobiologics market in EMEA
  • Orthobiologics market in APAC

PART 10: Market drivers

  • Popularity of spinal fusion surgeries
  • Rise in strategic partnerships for marketing
  • Prevalence of arthritis

PART 11: Impact of drivers

PART 12: Market challenges

  • High cost of spinal fusion surgery
  • Product side effects and FDA scrutiny
  • Poor performance of bone graft substitute

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Funds to enhance orthobiologics
  • Product development in collaboration with research institutes
  • Increase in M&A

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis
  • DePuy Synthes
  • Medtronic
  • Sanofi
  • Stryker
  • Zimmer Biomet
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings 7
  • Exhibit 02: Funding for orthobiologics development
  • Exhibit 03: Global orthobiologics market segmentation by product and procedure
  • Exhibit 04: Global orthobiologics market 2015-2020 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Global orthobiologics market by product 2015
  • Exhibit 07: Global orthobiologics market by stem cells 2015-2020 ($ millions)
  • Exhibit 08: Global orthobiologics market by bone morphogenetic proteins 2015-2020 ($ millions)
  • Exhibit 09: Global orthobiologics market by synthetic bone grafts 2015-2020 ($ millions)
  • Exhibit 10: Global orthobiologics market by viscosupplements 2015-2020 ($ billions)
  • Exhibit 11: Global orthobiologics market by demineralized bone matrix 2015-2020 ($ millions)
  • Exhibit 12: Global orthobiologics market by allografts 2015-2020 ($ millions)
  • Exhibit 13: Global orthobiologics market by procedure 2015
  • Exhibit 14: Global orthobiologics market by geography 2015
  • Exhibit 15: Orthobiologics market in Americas 2015-2020 ($ billions)
  • Exhibit 16: Orthobiologics market in EMEA 2015-2020 ($ billions)
  • Exhibit 17: Orthobiologics market in APAC 2015-2020 ($ millions)
  • Exhibit 18: Global orthobiologics market by geography 2015-2020
  • Exhibit 19: Impact of drivers
  • Exhibit 20: Impact of drivers and challenges
  • Exhibit 21: Ranking of vendors 2015
  • Exhibit 22: Competitive scenario of vendors 2015
  • Exhibit 23: Comparative analysis of vendors and their orthobiologic products
  • Exhibit 24: Collaboration between vendors and universities or organizations
  • Exhibit 25: DePuy Synthes: Key takeaways
  • Exhibit 26: DePuy Synthes: Business segmentation
  • Exhibit 27: Medtronic: Key takeaways
  • Exhibit 28: Medtronic: Business segmentation by revenue 2015
  • Exhibit 29: Sanofi: Key takeaways
  • Exhibit 30: Sanofi: Product revenue 2014
  • Exhibit 31: Sanofi: Product revenue comparison 2013 and 2014 ($ millions)
  • Exhibit 32: Stryker: Key takeaways
  • Exhibit 33: Stryker: Business segmentation by revenue 2014
  • Exhibit 34: Stryker: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 35: Stryker: Geographical segmentation by revenue 2014
  • Exhibit 36: Zimmer Biomet: Key takeaways
  • Exhibit 37: Zimmer Biomet: Business segmentation by revenue 2014
  • Exhibit 38: Zimmer Biomet: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 39: Zimmer Biomet: Geographical segmentation by revenue 2014
Back to Top